Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Journal of the American Chemical Society|December 6, 2001
DFT studies on the copolymerization of alpha-olefins with polar monomers: ethylene-methyl acrylate copolymerization catalyzed by a Pd-based diimine catalystA Michalak, T ZieglerHepatology (Baltimore, Md.)|March 1, 1997
Selective loss of binding sites for the glutamate receptor ligands [3H]kainate and (S)-[3H]5-fluorowillardiine in the brains of rats with acute liver failureA Michalak, R F ButterworthBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Tissue acylcarnitine and acyl-coenzyme A profiles in chronically hyperammonemic mice treated with sodium benzoate and supplementary L-carnitineA Michalak, I A QureshiBiochemical Medicine and Metabolic Biology|April 1, 1990
Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatmentA Michalak, I A QureshiMetabolic Brain Disease|November 5, 1997
Ornithine transcarbamylase deficiency: pathogenesis of the cerebral disorder and new prospects for therapyA Michalak, R F ButterworthCanadian Journal of Physiology and Pharmacology|July 1, 1993
[Carnitine levels in muscle in mice with hyperammonemia: effect of treatment with sodium benzoate]A Michalak, I A QureshiAnnales De Biologie Clinique|January 1, 1993
[Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study]A Michalak, I A QureshiMetabolic Brain Disease|February 25, 1998
Selective increases of extracellular brain concentrations of aromatic and branched-chain amino acids in relation to deterioration of neurological status in acute (ischemic) liver failureA Michalak, R F ButterworthBiochemical and Molecular Medicine|April 1, 1995
Free and esterified coenzyme A in the liver and muscles of chronically hyperammonemic mice treated with sodium benzoateA Michalak, I A QureshiPediatria Polska|January 1, 1996
[Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?]E Masłowska, M Wysocki, A Michalak-NowaczykPageof 4